Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Not stated	2026-10-09		NCT02622581

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AIO-Studien-gGmbH	9
Amgen	180
Astellas Pharma Global Development, Inc.	43
AstraZeneca	806
Boehringer Ingelheim	158
Bristol-Myers Squibb	422
Celgene Corporation	20
Daiichi Sankyo Deutschland GmbH	1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company	8
Eli Lilly and Company	370
Gilead Sciences	180
GlaxoSmithKline	294
iOMEDICO AG	19
Janssen-Cilag G.m.b.H	6
Merck Sharp & Dohme LLC	650
Novartis Pharmaceuticals	432
Pfizer	431
Regeneron Pharmaceuticals	238
Roche Pharma AG	59
Takeda	163

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Pius-Hospital	Oldenburg	Germany	2

Clinical trials